McGuigan L, Edmonds J, Wellings G, Jones M
J Rheumatol. 1984 Apr;11(2):172-4.
The most specific serological test for systemic lupus erythematosus (SLE) is the detection of anti-dsDNA antibodies by the Farr or Crithidia luciliae (CL) assay. Serological interpretation is difficult when these assays give discrepant results (i.e., one is positive and the other negative). In the present study 34 patients with discrepant results (18 CL positive Farr negative; 16 CL negative Farr positive) were reviewed to determine whether they fulfilled ARA criteria for SLE at presentation or at follow up 1-50 months (mean 15.8 months) later. Only 2 patients had SLE, both of whom fulfilled ARA criteria at presentation. Discrepant CL and Farr assays are associated with SLE uncommonly and rarely precede the development of clinical lupus.
用于系统性红斑狼疮(SLE)的最具特异性的血清学检测是通过Farr法或利什曼原虫(CL)检测法检测抗双链DNA抗体。当这些检测结果不一致时(即一个为阳性而另一个为阴性),血清学解释就很困难。在本研究中,对34例结果不一致的患者(18例CL阳性Farr阴性;16例CL阴性Farr阳性)进行了回顾,以确定他们在就诊时或1至50个月(平均15.8个月)后的随访中是否符合美国风湿病学会(ARA)的SLE标准。只有2例患者患有SLE,两者在就诊时均符合ARA标准。CL和Farr检测结果不一致与SLE的关联不常见,且很少先于临床狼疮的发生。